| Vactosertib | TEW-7197; EW-7197; NOV-1301 | Phase 3 Clinical | Medpacto Inc | Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Osteosarcoma; Solid tumours; Stomach Neoplasms; Urologic Neoplasms | 詳細 |
| Bintrafusp alfa | M-7824; GSK-4045154; MSB-0011359C | Phase 3 Clinical | Merck Serono | Anus Neoplasms; Biliary Tract Neoplasms; Brain metastases; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Esthesioneuroblastoma, Olfactory; Gallbladder Neoplasms; Ganglioglioma; Head and Neck Neoplasms; Hematologic Neoplasms; Intestinal Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Metastatic breast cancer; Microsatellite Instability; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Germ Cell and Embryonal; Nose Neoplasms; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Penile Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Respiratory papillomatosis; Sarcoma; Sarcoma, Kaposi; Skin Melanoma; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thymic epithelial tumor; Thymoma; Thymus Neoplasms; Triple Negative Breast Neop | 詳細 |
| Nisevokitug | NIS-793 | Phase 3 Clinical | Xoma Corp | Adenocarcinoma; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Myelodysplastic Syndromes; Pancreatic Neoplasms; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential | 詳細 |
| Yinfenidone Hydrochloride | HEC-585; HEC-00000585 | Phase 3 Clinical | Hec Pharm Co Ltd | Idiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis | 詳細 |
| SB-01 (Ensol BioSciences) | Peniel-2000; SB-01; Peniel 2K; YH14618; YH-14618; P2K | Phase 3 Clinical | Ensol Biosciences Inc | Intervertebral Disc Degeneration; Intervertebral disc disease; Low Back Pain | 詳細 |
| Livmoniplimab | MGH-8; AGRX-115; ABBV-151; MHG-8; ARGX-115 | Phase 3 Clinical | Argenx Se | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Solid tumours | 詳細 |
| Dalutrafusp alfa | GS-1423; AGEN-1423 | Phase 2 Clinical | Agenus Inc | Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours | 詳細 |
| ZSP-1603 | ZSP-1603 | Phase 2 Clinical | Guangdong Zhongsheng Pharmaceutical Co Ltd, Wuxi Apptec Co Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Idiopathic Pulmonary Fibrosis; Liver Neoplasms; Ovarian Neoplasms; Solid tumours; Thyroid Neoplasms | 詳細 |
| Nicousamide | XLF-III-43 | Phase 2 Clinical | Institue Of Materia Medica Chinese Academy Of Medical Science | Diabetic Nephropathies; Hypertensive nephropathy | 詳細 |
| Meflonidone hydrochloride | | Phase 2 Clinical | Central South University, Guangzhou Nanxin Pharma Co Ltd | Diabetes Mellitus, Type 2; Diabetic Nephropathies | 詳細 |
| Fluorofenidone | AKF-PD | Phase 2 Clinical | Central South University, Dierepharma HK Ltd, Hainan Haiyao Co Ltd | Hepatitis B, Chronic; Liver Cirrhosis | 詳細 |
| Cotsiranib | STP-705LU; STP-705LV; STP-705; STP-705L | Phase 2 Clinical | Sirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd | Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cicatrix, Hypertrophic; Keloid; Liver Neoplasms; Obesity, Abdominal | 詳細 |
| YL-13027 | YL-13027 | Phase 2 Clinical | YL-Pharma | Pancreatic Neoplasms; Solid tumours | 詳細 |
| MR-001 | MR001; MR-001 | Phase 2 Clinical | Shenzhen Maijiarui Biotechnology Co Ltd | Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| Linavonkibart | SRK-181; SRT-BETA-1-AB3 | Phase 1 Clinical | Scholar Rock Inc | | 詳細 |
| Charis-1000 | Charis-1000; C 1K; C1K | Phase 1 Clinical | Ensol Biosciences Inc | | 詳細 |
| HLX-6018 | HLX-6018; HLX6018 | Phase 1 Clinical | | Idiopathic Pulmonary Fibrosis | 詳細 |
| RO7496353 | RO7496353; RO-7496353; SOF 10; RG6440; RG-6440 | Phase 1 Clinical | Genentech Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours; Stomach Neoplasms | 詳細 |
| JYB-1907 | JYB-1907 | Phase 1 Clinical | Jiangxi Jemincare Group Co Ltd | | 詳細 |
| STP-707 | STP-707; STP707 | Phase 1 Clinical | Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd | Cholangitis, Sclerosing; Liver Cirrhosis; Liver Neoplasms; Pancreatic Neoplasms; Pulmonary Fibrosis; Solid tumours | 詳細 |
| PXS-64 | PXS-64 | Phase 1 Clinical | Syntara Ltd | | 詳細 |
| BMS-986416 | BMS-986416; AVID-200 DP; AVID-200 | Phase 1 Clinical | Formation Biologics Corp | Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Solid tumours; Thrombocythemia, Essential | 詳細 |